Novel insertion sites in pox vectors
Details for Australian Patent Application No. 2004291024 (hide)
International Classifications
Event Publications
25 August 2005 PCT application entered the National Phase
PCT publication WO2005/048957 Priority application(s): WO2005/048957
25 October 2007 Assignment before Grant
Therion Biologics Corporation The application has been assigned to Government of the United States of America, represented by the Secretary, Department of Health and Human Services
17 September 2009 Application Accepted
Published as AU-B-2004291024
21 January 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004291026-Use of EphA4 and modulator or EphA4 for diagnosis, treatment and prevention of cancer
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser